...
首页> 外文期刊>Chromatographia >Development of high performance liquid chromatography tandem mass spectrometric methods for the determination of a novel ascomycin-based immunoregulant in human whole blood and plasma: A case of potential analyte loss during sample collection
【24h】

Development of high performance liquid chromatography tandem mass spectrometric methods for the determination of a novel ascomycin-based immunoregulant in human whole blood and plasma: A case of potential analyte loss during sample collection

机译:高效液相色谱串联质谱法测定人全血和血浆中新型基于子囊霉素的免疫调节剂的开发:样品收集过程中潜在分析物损失的案例

获取原文
获取原文并翻译 | 示例

摘要

Methods for the determination of a novel, ascomycin-based macrolide immunosuppressant in human plasma and whole blood are described. Following protein precipitation, the analyte and an internal standard were extracted from each matrix using solid phase extraction on an end-capped cyano column. The analytes were chromatographed on a Zorbax SB-CN analytical column (5.0 mum, 150 x 4.6 mm) with a mobile phase consisting of 70:30:0.1 v/v/v acetonitrile/ammonium acetate (10 mM)/formic acid. A tandem mass spectrometer equipped with an APCl interface was used as the detector. Multiple reaction monitoring using the parent --> product ion combinations of m/z 1009 --> 217 and 979 --> 187 was used to detect the analyte and internal standard, respectively. Seven point calibration curves over the concentration range of 0.25 - 20 ng mL(-1) yielded a linear response when a 1/y weighted linear regression model was employed. Based on the replicate analyses (n = 5) of spiked standards, the within-day assay precision for both assays was better than 75% C.V at all points on the calibration curves. The within-day accuracy for both assays was within 5% of nominal at all standard concentrations. The between-run precision of each of the assays, as calculated from the results of the analysis of quality control samples, was better than 5% C.V. A special collection procedure for whole blood, in which samples were stored in the tubes that were used in the initial step of the assay procedure, was developed to eliminate assay error resulting from adsorption of the analyte to the sample storage tube. [References: 11]
机译:描述了测定人血浆和全血中新型基于子囊霉素的大环内酯类免疫抑制剂的方法。蛋白质沉淀后,使用封端氰基柱上的固相萃取从每个基质中萃取分析物和内标。将分析物在Zorbax SB-CN分析柱(5.0 mum,150 x 4.6 mm)上进行色谱分离,流动相由70:30:0.1 v / v / v乙腈/乙酸铵(10 mM)/甲酸组成。装有APCl接口的串联质谱仪用作检测器。使用m / z 1009-> 217和979-> 187的母体->产物离子组合进行的多反应监测分别用于检测分析物和内标。当采用1 / y加权线性回归模型时,在0.25-20 ng mL(-1)浓度范围内的七点校准曲线产生线性响应。根据加标标准品的重复分析(n = 5),两种测定的日内测定精度在校准曲线的所有点上均优于75%C.V。在所有标准浓度下,两种测定的日内准确度均在标称值的5%以内。从质量控制样品的分析结果计算出的每个测定的批间精密度均优于5%C.V.开发了一种用于全血的特殊收集程序,其中将样品存储在用于分析程序初始步骤的试管中,以消除由于分析物吸附到样品存储管而导致的分析误差。 [参考:11]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号